Evidence map›Paper›PMID 26852328›Full record

ArticleCellular and molecular neurobiology2016

SCN2B in the Rat Trigeminal Ganglion and Trigeminal Sensory Nuclei.

Yusuke Shimada, Tadasu Sato, Takehiro Yajima, Masatoshi Fujita, Naoya Hashimoto, Noriaki Shoji, Takashi Sasano, Hiroyuki Ichikawa

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yusuke ShimadaDivision of Oral Diagnosis, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan.
Tadasu SatoDivision of Oral and Craniofacial Anatomy, Graduate School of Dentistry, Tohoku University, 4-1 Seiryo-machi, Sendai, 980-8575, Japan.
Takehiro YajimaDivision of Operative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan.
Masatoshi FujitaDivision of Dental Anesthesiology and Pain Management, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan.
Naoya HashimotoDivision of Oral Diagnosis, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan.
Noriaki ShojiDivision of Oral Diagnosis, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan.
Takashi SasanoDivision of Oral Diagnosis, Graduate School of Dentistry, Tohoku University, Sendai, 980-8575, Japan.
Hiroyuki IchikawaDivision of Oral and Craniofacial Anatomy, Graduate School of Dentistry, Tohoku University, 4-1 Seiryo-machi, Sendai, 980-8575, Japan. hiroichi@anat.dent.tohoku.ac.jp.
Tohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The beta-2 subunit of the mammalian brain voltage-gated sodium channel (SCN2B) was examined in the rat trigeminal ganglion (TG) and trigeminal sensory nuclei. In the TG, 42.6 % of sensory neurons were immunoreactive (IR) for SCN2B. These neurons had various cell body sizes. In facial skins and oral mucosae, corpuscular nerve endings contained SCN2B-immunoreactivity. SCN2B-IR nerve fibers formed nerve plexuses beneath taste buds in the tongue and incisive papilla. However, SCN2B-IR free nerve endings were rare in cutaneous and mucosal epithelia. Tooth pulps, muscle spindles and major salivary glands were also innervated by SCN2B-IR nerve fibers. A double immunofluorescence method revealed that about 40 % of SCN2B-IR neurons exhibited calcitonin gene-related peptide (CGRP)-immunoreactivity. However, distributions of SCN2B- and CGRP-IR nerve fibers were mostly different in facial, oral and cranial structures. By retrograde tracing method, 60.4 and 85.3 % of TG neurons innervating the facial skin and tooth pulp, respectively, showed SCN2B-immunoreactivity. CGRP-immunoreactivity was co-localized by about 40 % of SCN2B-IR cutaneous and tooth pulp TG neurons. In trigeminal sensory nuclei of the brainstem, SCN2B-IR neuronal cell bodies were common in deep laminae of the subnucleus caudalis, and the subnuclei interpolaris and oralis. In the mesencephalic trigeminal tract nucleus, primary sensory neurons also exhibited SCN2B-immunoreactivity. In other regions of trigeminal sensory nuclei, SCN2B-IR cells were very infrequent. SCN2B-IR neuropil was detected in deep laminae of the subnucleus caudalis as well as in the subnuclei interpolaris, oralis and principalis. These findings suggest that SCN2B is expressed by various types of sensory neurons in the TG. There appears to be SCN2B-containing pathway in the TG and trigeminal sensory nuclei.

Indexed as

AnimalsCalcitonin Gene-Related PeptideFaceMaleMouthRatsRats, WistarSensory Receptor CellsSkullTrigeminal GanglionTrigeminal NucleiVoltage-Gated Sodium Channel beta-2 SubunitCalcitonin Gene-Related PeptideSCN2B protein, ratVoltage-Gated Sodium Channel beta-2 SubunitFacial skinSCN2BTooth pulpTrigeminal ganglionTrigeminal sensory nucleusVibrissa

Identifiers

PMID26852328
PMCPMC11482371
OpenAlexW2261073378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.